Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Inappropriate Prescriptions for Elderly Pose Serious Health Risk: Group March 18, 2013 Irvin Jackson Add Your Comments The prominent consumer watchdog group Public Citizen is warning about the continuing dangers associated with inappropriate prescription drugs that are commonly given to elderly patients. In the most recent issue of Public Citizen’s Worst Pills, Best Pills newsletter, the group highlights the risks that come with misprescribing drugs to older patients, calling it a dangerous and persistent problem in the United States and around the world. “In the U.S. alone, misprescribing ultimately leads to millions of preventable adverse events and more than 100,000 deaths annually,” the group notes in the newsletter. “It wastes billions of dollars within our health care system.” Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The newsletter points to a study published last year that found that about 20% of prescriptions for elderly patients in a primary care setting, like a nursing home, were inappropriate over the last 15 years. The most commonly misprescribed drug was propoxyphene, a painkiller that was removed from the market in 2010. The second most commonly misprescribed drug is Cardura, a blood pressure medication that some studies have found to have higher risks than similar drugs, but is less effective. The other most commonly misprescribed drugs for elderly patients are Benadryl and amitriptyline-based antidepressants like Elavil, Tryptomer, Tryptizol and Saroten. “Such misprescribing typically occurs when a doctor prescribes a drug even when it is contraindicated because of a patient’s age, underlying medical condition or use of other drugs, or when the prescribed dose is too high or the prescribed duration of use is too long,” according to the Public Citizen newsletter. “In many cases, especially in the elderly, prescribing is inappropriate because safer alternatives, either other drugs or nondrug interventions, are available.” Concerns Over Antipsychotic Drug Prescriptions for Elderly Last year also saw increasing concern over the use of antipsychotic drugs for the treatment of dementia among older patients. Some experts have suggested that such drugs have been increasingly used in many nursing homes as a form of chemical restraint. Other concerns have been raised that use of the medications may increase the risk of falls and deaths, without providing any benefit to the patient. In May 2012, a special report by the Boston Globe found that about 185,000 nursing home residents nationwide were prescribed antipsychotic medications in 2010, even though they had none of the conditions for which the drugs had been approved to treat. The widespread overuse of antipsychotic medications, such as Risperdal, Seroquel, Zyprexa and Abilify, continues despite warnings issued by the FDA and other health experts indicating that the drugs should not to be used to treat patients with Alzheimer’s disease and dementia, because they may increase the risk of death for individuals with those conditions. Part of a class of medications known as atypical antipsychotics, the drugs are approved to treat a number of mental health problems, such as bipolar disorder and schizophrenia. However, they are also widely used “off-label” for ailments that have not been approved by the FDA, because the manufacturers have not established that they are safe or effective for those conditions. Nursing home officials have suggested that they are giving the drugs to some elderly residents to prevent them from harming themselves and others, but health experts say that the drugs place the elderly residents in a stupor, increasing the risk of nursing home falls and other problems. The chemical restraints also lower their quality of life by leaving them in a perpetual state of mind-numbed sedation, causing many to consider the use of the drugs in these situations to be a form of nursing home abuse. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Chemical Restraint, Medication Error, Nursing Home More Risperdal Lawsuit Stories Risperdal Side Effects Led to Deadly Breast Cancer, Lawsuit Claims January 7, 2026 Court Considers Remanding Risperdal Breast Cancer Lawsuit to California State Court October 29, 2025 Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders December 14, 2022 0 Comments URLThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Depo-Provera Brain Tumor Risks Make Birth Control Shot Unreasonably Dangerous: Lawsuit (Posted: 2 days ago) A New York woman has filed a lawsuit alleging that her long term use of Depo Provera caused her to develop a meningioma brain tumor, which she contends resulted from the manufacturer’s negligence and failure to adequately warn about the risks. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Indicates Depo-Provera Meningioma Lawsuits Should Be Preempted by Federal Law (02/03/2026)Proposed Depo-Provera Lawsuit Schedule Calls for First Trial in Dec. 2026 (01/23/2026)Lawsuit Indicates Depo-Provera Meningioma Diagnosis Followed Memory Loss, Dizziness Symptoms (01/20/2026) MDL Sought for Dupixent Lymphoma Lawsuits Filed in Federal Courts Nationwide (Posted: 3 days ago) A group of plaintiffs has petitioned the U.S. Judicial Panel on Multidistrict Litigation to centralize all Dupixent lymphoma lawsuits before a single judge for coordinated pretrial proceedings, a move that could ultimately lead to bellwether trials and a global resolution of the claims. MORE ABOUT: DUPIXENT LAWSUITLawsuit Claims Dupixent for Atopic Dermatitis, Eczema Treatment Caused CTCL (02/10/2026)CTCL Diagnosis Leads to Lawsuit Over Dupixent Cancer Risks (02/03/2026)Lawsuit Claims Dupixent Side Effects Led to CTCL Cancer Diagnosis (01/12/2026) $7.25B Roundup Class Settlement Proposed To Resolve Non-Hodgkin’s Lymphoma Lawsuits (Posted: 4 days ago) Bayer and Monsanto say they have reached a $7.25 billion Roundup cancer lawsuit settlement resolving more than 100,000 claims as well as any future litigation that may be filed. MORE ABOUT: ROUNDUP LAWSUITSRoundup Settlement Program Remains Option With Supreme Court Review Pending: MDL Judge (02/09/2026)Future of Roundup Lawsuits Over Non-Hodgkin’s Lymphoma To Be Decided by U.S. Supreme Court (01/19/2026)Roundup Safety Study Retracted Decades After Publication (12/08/2025)
Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders December 14, 2022
Depo-Provera Brain Tumor Risks Make Birth Control Shot Unreasonably Dangerous: Lawsuit (Posted: 2 days ago) A New York woman has filed a lawsuit alleging that her long term use of Depo Provera caused her to develop a meningioma brain tumor, which she contends resulted from the manufacturer’s negligence and failure to adequately warn about the risks. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Indicates Depo-Provera Meningioma Lawsuits Should Be Preempted by Federal Law (02/03/2026)Proposed Depo-Provera Lawsuit Schedule Calls for First Trial in Dec. 2026 (01/23/2026)Lawsuit Indicates Depo-Provera Meningioma Diagnosis Followed Memory Loss, Dizziness Symptoms (01/20/2026)
MDL Sought for Dupixent Lymphoma Lawsuits Filed in Federal Courts Nationwide (Posted: 3 days ago) A group of plaintiffs has petitioned the U.S. Judicial Panel on Multidistrict Litigation to centralize all Dupixent lymphoma lawsuits before a single judge for coordinated pretrial proceedings, a move that could ultimately lead to bellwether trials and a global resolution of the claims. MORE ABOUT: DUPIXENT LAWSUITLawsuit Claims Dupixent for Atopic Dermatitis, Eczema Treatment Caused CTCL (02/10/2026)CTCL Diagnosis Leads to Lawsuit Over Dupixent Cancer Risks (02/03/2026)Lawsuit Claims Dupixent Side Effects Led to CTCL Cancer Diagnosis (01/12/2026)
$7.25B Roundup Class Settlement Proposed To Resolve Non-Hodgkin’s Lymphoma Lawsuits (Posted: 4 days ago) Bayer and Monsanto say they have reached a $7.25 billion Roundup cancer lawsuit settlement resolving more than 100,000 claims as well as any future litigation that may be filed. MORE ABOUT: ROUNDUP LAWSUITSRoundup Settlement Program Remains Option With Supreme Court Review Pending: MDL Judge (02/09/2026)Future of Roundup Lawsuits Over Non-Hodgkin’s Lymphoma To Be Decided by U.S. Supreme Court (01/19/2026)Roundup Safety Study Retracted Decades After Publication (12/08/2025)